Trial
NCT03439514
A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Pfizer
Collaborators
—
Condition
Dilated Cardiomyopathy
Intervention
ARRY-371797 (PF-07265803)
Why stopped
The Sponsor terminated the study due to futility. The decision to stop the study was not based on safety concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-01-09